IPP Bureau

Procter & Gamble Health posts 14 per cent growth in net profit in Q3
Procter & Gamble Health posts 14 per cent growth in net profit in Q3

By IPP Bureau - May 06, 2022

The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year

USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously
USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously

By IPP Bureau - May 06, 2022

Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously

USFDA limits use of J&J Covid-19 vaccine to certain individuals
USFDA limits use of J&J Covid-19 vaccine to certain individuals

By IPP Bureau - May 06, 2022

The FDA has determined that the known and potential benefits of the vaccine for the prevention of Covid-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved vaccines are not accessible

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’
ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’

By IPP Bureau - May 06, 2022

The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups

Lupin receives USFDA approval for Pregabalin and Iloperidone
Lupin receives USFDA approval for Pregabalin and Iloperidone

By IPP Bureau - May 06, 2022

While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility

Zydus receives tentative approval from USFDA for Selexipag tablets
Zydus receives tentative approval from USFDA for Selexipag tablets

By IPP Bureau - May 06, 2022

The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad

ACG appoints Udit K Singh as CEO of its Inspection division
ACG appoints Udit K Singh as CEO of its Inspection division

By IPP Bureau - May 06, 2022

He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended

IGSTC to propose joint AI initiative on healthcare and sustainability
IGSTC to propose joint AI initiative on healthcare and sustainability

By IPP Bureau - May 05, 2022

This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems

Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India
Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India

By IPP Bureau - May 05, 2022

The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology

JBCPL emerges as the fastest growing pharma company: Report
JBCPL emerges as the fastest growing pharma company: Report

By IPP Bureau - May 05, 2022

Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22

USFDA permits marketing for new test to improve diagnosis of Alzheimer's disease
USFDA permits marketing for new test to improve diagnosis of Alzheimer's disease

By IPP Bureau - May 05, 2022

According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills

Promising new universal coronavirus vaccine candidate discovered
Promising new universal coronavirus vaccine candidate discovered

By IPP Bureau - May 05, 2022

Formula attenuates 99% of 365 coronaviruses in computer models

Mediso acquires nuclear medicine supplier Bartec Technologies
Mediso acquires nuclear medicine supplier Bartec Technologies

By IPP Bureau - May 05, 2022

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership

TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea
TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea

By IPP Bureau - May 05, 2022

The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness

Fear of fourth wave drives Indians to search Covid health services
Fear of fourth wave drives Indians to search Covid health services

By IPP Bureau - May 05, 2022

Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%

Latest Stories

Interviews

Packaging